熱門資訊> 正文
Elanco的Credelio CAT获得FDA紧急使用授权
2025-11-22 04:14
- Elanco Animal Health (ELAN) has received Emergency Use Authorization from the U.S. FDA for its product, Credelio CAT, which is designed to treat New World screwworm infestations in cats.
- This authorization is based on research that assessed the effectiveness of Credelio CAT against Old World screwworms in cats and the performance of Credelio in treating New World screwworms in dogs.
More on Elanco
- Elanco Animal Health: What A Difference An Innovation Year Makes
- Elanco Animal Health Incorporated (ELAN) Q3 2025 Earnings Call Transcript
- Elanco Animal Health Incorporated 2025 Q3 - Results - Earnings Call Presentation
- Elanco wins Overweight rating, Zoetis Sector Weight as KeyBanc reviews animal health space
- Elanco raises 2025 guidance to 6%–6.5% organic growth and $840M–$880M innovation revenue following strong Q3
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
